RELIEF-DPN-1 clinical trial : Lexicon begins patient dosing with LX9211
RELIEF-DPN-1 clinical trial : Lexicon Pharmaceuticals has started patient dosing in a phase 2 trial of LX9211 for the treatment of diabetic peripheral neuropathic pain. ... Read More
FDA approves Lexicon Pharmaceuticals’ Xermelo for carcinoid syndrome diarrhea
Lexicon Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its oral drug Xermelo (telotristat ethyl) 250mg, to be used in ... Read More